AI Science Tracker
EN

Identification of DNA damage response and crotonylation-related biomarkers for lung adenocarcinoma via machine learning and WGCNA.

Affiliation not stated in the reviewed material · 30 Jul 2025 · medicine

Discovery

Identification of DNA damage response and crotonylation-related biomarkers for lung adenocarcinoma via machine learning and WGCNA.

Source check: Source checked. Not independent scientific confirmation.

Finding: WGCNA and three machine-learning feature-selection methods applied to LUAD transcriptomes from GSE27262 and GSE140797 yielded candidate DNA-damage-response/crotonylation hub genes; cell cytotoxicity assays provided follow-up checks. These are hypothesis-generating candidates, not demonstrated clinical biomarkers.

Technology: WGCNA and three machine-learning feature-selection methods identify candidate DNA-damage-response/crotonylation genes in lung-adenocarcinoma transcriptomes.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
WGCNA and three machine-learning feature-selection methods identify candidate DNA-damage-response/crotonylation genes in lung-adenocarcinoma transcriptomes.
Test and result
Two transcriptomic datasets, database analyses and cell cytotoxicity checks; the candidates are not validated clinical biomarkers.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study; author affiliation is not stated in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1007/s10238-025-01704-0 · https://link.springer.com/content/pdf/10.1007/s10238-025-01704-0.pdf · https://api.crossref.org/works/10.1007%2Fs10238-025-01704-0

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.